- Published on
KembaraXtra- Medicine- Aortic Regurgitation
Aortic regurgitation (AR), also known as aortic insufficiency, is a condition characterized by abnormal retrograde flow of blood from the aorta into the left ventricle during diastole due to incomplete closure of the aortic valve. This inadequate valve closure may result from intrinsic disease of the aortic valve leaflets or from pathology involving the aortic root or ascending aorta, such as dilation. Aortic regurgitation may be acute or chronic in nature. Chronic AR is further classified into stages: Stage A refers to patients at risk for AR without even trace regurgitation (for example, those with bicuspid aortic valves, aortic valve sclerosis, aortic root disease, or a history of rheumatic heart disease or infective endocarditis); Stage B includes patients with progressive mild to moderate AR and preserved left ventricular ejection fraction (LVEF); Stage C includes asymptomatic patients with severe AR, subdivided into those with preserved LVEF (C1) and those with reduced LVEF (C2); and Stage D includes patients with symptomatic severe AR.
The epidemiology of AR varies according to severity, age, and sex. Mild AR becomes increasingly common with advancing age, while moderate to severe AR remains less frequent but rises in prevalence among older adults. In developing countries, the most common cause of AR is rheumatic heart disease. In developed countries, aortic root dilation, congenital bicuspid aortic valve, and degenerative calcific valve disease are the predominant causes. Infective endocarditis is the most common cause of acute AR. Other causes include leaflet abnormalities such as trauma with valvular rupture, myxomatous degeneration, drug-induced valve disease (e.g., fenfluramine, dexfenfluramine, pergolide, cabergoline), congenital heart disease (including bicuspid aortic valve and sinus of Valsalva aneurysm), systemic inflammatory or rheumatologic disorders (such as ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus), and iatrogenic injury (e.g., following aortic balloon valvotomy). Abnormalities of the aortic root or ascending aorta, including annuloaortic ectasia, connective tissue disorders (Marfan syndrome, Ehlers-Danlos syndrome), trauma, syphilitic aortitis, systemic hypertension, and aortic dissection, are also important etiologies. Postprocedural AR, most often due to paravalvular leak, occurs in a notable proportion of patients after transcatheter aortic valve replacement (TAVR) and is associated with worse outcomes when more than mild.
Clinical presentation depends on whether AR is acute or chronic. Chronic AR is often well tolerated for many years because of compensatory left ventricular dilation and hypertrophy. Symptoms typically appear when left ventricular systolic function deteriorates and include dyspnea on exertion, decreased exercise tolerance, chest pain, syncope, and signs of congestive heart failure. Acute severe AR presents dramatically, often with hypotension, pulmonary edema, and cardiogenic shock, due to the inability of the left ventricle to accommodate the sudden volume overload. In acute AR, the rapid rise in left ventricular diastolic pressure reduces coronary perfusion, further worsening hemodynamics.
Physical examination findings in chronic AR are largely related to increased stroke volume and widened pulse pressure. These include bounding or “water-hammer” pulses (Corrigan pulse), head bobbing with each heartbeat (de Musset sign), loud systolic and diastolic femoral sounds (“pistol-shot” femorals or Traube sign), capillary pulsations of the nail beds or lips (Quincke sign), and a to-and-fro femoral murmur with compression of the femoral artery (Duroziez sign). A significant increase in popliteal systolic pressure compared with brachial pressure (Hill sign) may be present. Historical signs such as uvular pulsation (Mueller sign), retinal arterial pulsations (Becker sign), diastolic blood pressure drop with arm elevation (Mayne sign), hepatic pulsations (Rosenbach sign), splenic pulsations (Gerhard sign), and pupillary changes (Landolfi sign) are neither sensitive nor specific but may be noted. Cardiac auscultation typically reveals a high-pitched, blowing, decrescendo diastolic murmur best heard along the left sternal border, an S3 at the apex, displacement of the apical impulse downward and laterally, and sometimes an Austin Flint murmur, which is a low-pitched apical diastolic rumble related to altered mitral inflow dynamics. In acute AR, these classic peripheral signs are often absent, and a short, soft diastolic murmur may be the only auscultatory finding.
The diagnostic evaluation of AR includes a careful history and physical examination, with particular attention to symptoms of exertional dyspnea, chest pain, syncope, and heart failure. Echocardiography is the cornerstone of diagnosis and is used to confirm AR, determine severity, assess valve anatomy, and evaluate left ventricular size and systolic function. Severity can be assessed qualitatively (e.g., vena contracta width) and quantitatively using effective regurgitant orifice area, regurgitant volume, and regurgitant fraction. Evidence of left ventricular dilation is required for the diagnosis of chronic severe AR. Chest radiography may demonstrate left ventricular enlargement and aortic dilation in chronic AR, while acute AR may show pulmonary edema with a relatively normal cardiac silhouette. Electrocardiography is not diagnostic but often reveals left ventricular hypertrophy in chronic AR and helps assess for associated arrhythmias. When transthoracic echocardiographic images are suboptimal or discordant with clinical findings, transesophageal echocardiography, cardiac magnetic resonance imaging, or cardiac catheterization may be used to further define AR severity, ventricular function, and aortic dimensions.
Management strategies differ between acute and chronic AR. Acute severe AR is a medical and surgical emergency. Definitive treatment is urgent aortic valve replacement or repair. Medical stabilization includes afterload reduction with vasodilators such as nitroprusside and treatment of pulmonary edema with diuretics. Beta-blockers are avoided because they prolong diastole and worsen regurgitation, and intra-aortic balloon pump support is contraindicated. Immediate surgical referral is required in cases of cardiogenic shock.
Chronic AR management depends on symptom status, severity of regurgitation, left ventricular systolic function, and ventricular dimensions. According to ACC/AHA guidelines, aortic valve replacement is indicated for symptomatic patients with severe AR regardless of LVEF and for asymptomatic patients with severe AR and LVEF less than 55%. Surgery is also indicated in patients with severe AR who are undergoing other cardiac surgery. In selected asymptomatic patients with preserved LVEF but significant left ventricular dilation, surgery may be reasonable if surgical risk is low. Medical therapy plays a supportive role and focuses on treating hypertension and heart failure symptoms. ACE inhibitors or angiotensin receptor blockers are recommended for blood pressure control, and diuretics with sodium restriction are used for congestive heart failure. Long-term vasodilator therapy has not consistently been shown to delay surgery in asymptomatic patients with severe AR but is appropriate for concomitant hypertension. Beta-blockers may be considered in patients with symptomatic severe AR or left ventricular dysfunction when surgery is not feasible, and observational studies suggest a potential survival benefit in such cases. For patients with pure aortic insufficiency who are not surgical candidates, TAVR may be considered, although it is associated with higher rates of certain complications compared with surgical valve replacement.
Referral for surgical or advanced cardiac evaluation is indicated in patients with acute severe AR, symptomatic severe AR, evidence of left ventricular systolic dysfunction, or significant ventricular dilation even in the absence of symptoms. With timely intervention and appropriate long-term follow-up, outcomes in patients with chronic AR can be significantly improved, particularly when surgery is performed before irreversible left ventricular dysfunction develops.
Aortic regurgitation (AR), also known as aortic insufficiency, is a condition characterized by abnormal retrograde flow of blood from the aorta into the left ventricle during diastole due to incomplete closure of the aortic valve. This inadequate valve closure may result from intrinsic disease of the aortic valve leaflets or from pathology involving the aortic root or ascending aorta, such as dilation. Aortic regurgitation may be acute or chronic in nature. Chronic AR is further classified into stages: Stage A refers to patients at risk for AR without even trace regurgitation (for example, those with bicuspid aortic valves, aortic valve sclerosis, aortic root disease, or a history of rheumatic heart disease or infective endocarditis); Stage B includes patients with progressive mild to moderate AR and preserved left ventricular ejection fraction (LVEF); Stage C includes asymptomatic patients with severe AR, subdivided into those with preserved LVEF (C1) and those with reduced LVEF (C2); and Stage D includes patients with symptomatic severe AR.
The epidemiology of AR varies according to severity, age, and sex. Mild AR becomes increasingly common with advancing age, while moderate to severe AR remains less frequent but rises in prevalence among older adults. In developing countries, the most common cause of AR is rheumatic heart disease. In developed countries, aortic root dilation, congenital bicuspid aortic valve, and degenerative calcific valve disease are the predominant causes. Infective endocarditis is the most common cause of acute AR. Other causes include leaflet abnormalities such as trauma with valvular rupture, myxomatous degeneration, drug-induced valve disease (e.g., fenfluramine, dexfenfluramine, pergolide, cabergoline), congenital heart disease (including bicuspid aortic valve and sinus of Valsalva aneurysm), systemic inflammatory or rheumatologic disorders (such as ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus), and iatrogenic injury (e.g., following aortic balloon valvotomy). Abnormalities of the aortic root or ascending aorta, including annuloaortic ectasia, connective tissue disorders (Marfan syndrome, Ehlers-Danlos syndrome), trauma, syphilitic aortitis, systemic hypertension, and aortic dissection, are also important etiologies. Postprocedural AR, most often due to paravalvular leak, occurs in a notable proportion of patients after transcatheter aortic valve replacement (TAVR) and is associated with worse outcomes when more than mild.
Clinical presentation depends on whether AR is acute or chronic. Chronic AR is often well tolerated for many years because of compensatory left ventricular dilation and hypertrophy. Symptoms typically appear when left ventricular systolic function deteriorates and include dyspnea on exertion, decreased exercise tolerance, chest pain, syncope, and signs of congestive heart failure. Acute severe AR presents dramatically, often with hypotension, pulmonary edema, and cardiogenic shock, due to the inability of the left ventricle to accommodate the sudden volume overload. In acute AR, the rapid rise in left ventricular diastolic pressure reduces coronary perfusion, further worsening hemodynamics.
Physical examination findings in chronic AR are largely related to increased stroke volume and widened pulse pressure. These include bounding or “water-hammer” pulses (Corrigan pulse), head bobbing with each heartbeat (de Musset sign), loud systolic and diastolic femoral sounds (“pistol-shot” femorals or Traube sign), capillary pulsations of the nail beds or lips (Quincke sign), and a to-and-fro femoral murmur with compression of the femoral artery (Duroziez sign). A significant increase in popliteal systolic pressure compared with brachial pressure (Hill sign) may be present. Historical signs such as uvular pulsation (Mueller sign), retinal arterial pulsations (Becker sign), diastolic blood pressure drop with arm elevation (Mayne sign), hepatic pulsations (Rosenbach sign), splenic pulsations (Gerhard sign), and pupillary changes (Landolfi sign) are neither sensitive nor specific but may be noted. Cardiac auscultation typically reveals a high-pitched, blowing, decrescendo diastolic murmur best heard along the left sternal border, an S3 at the apex, displacement of the apical impulse downward and laterally, and sometimes an Austin Flint murmur, which is a low-pitched apical diastolic rumble related to altered mitral inflow dynamics. In acute AR, these classic peripheral signs are often absent, and a short, soft diastolic murmur may be the only auscultatory finding.
The diagnostic evaluation of AR includes a careful history and physical examination, with particular attention to symptoms of exertional dyspnea, chest pain, syncope, and heart failure. Echocardiography is the cornerstone of diagnosis and is used to confirm AR, determine severity, assess valve anatomy, and evaluate left ventricular size and systolic function. Severity can be assessed qualitatively (e.g., vena contracta width) and quantitatively using effective regurgitant orifice area, regurgitant volume, and regurgitant fraction. Evidence of left ventricular dilation is required for the diagnosis of chronic severe AR. Chest radiography may demonstrate left ventricular enlargement and aortic dilation in chronic AR, while acute AR may show pulmonary edema with a relatively normal cardiac silhouette. Electrocardiography is not diagnostic but often reveals left ventricular hypertrophy in chronic AR and helps assess for associated arrhythmias. When transthoracic echocardiographic images are suboptimal or discordant with clinical findings, transesophageal echocardiography, cardiac magnetic resonance imaging, or cardiac catheterization may be used to further define AR severity, ventricular function, and aortic dimensions.
Management strategies differ between acute and chronic AR. Acute severe AR is a medical and surgical emergency. Definitive treatment is urgent aortic valve replacement or repair. Medical stabilization includes afterload reduction with vasodilators such as nitroprusside and treatment of pulmonary edema with diuretics. Beta-blockers are avoided because they prolong diastole and worsen regurgitation, and intra-aortic balloon pump support is contraindicated. Immediate surgical referral is required in cases of cardiogenic shock.
Chronic AR management depends on symptom status, severity of regurgitation, left ventricular systolic function, and ventricular dimensions. According to ACC/AHA guidelines, aortic valve replacement is indicated for symptomatic patients with severe AR regardless of LVEF and for asymptomatic patients with severe AR and LVEF less than 55%. Surgery is also indicated in patients with severe AR who are undergoing other cardiac surgery. In selected asymptomatic patients with preserved LVEF but significant left ventricular dilation, surgery may be reasonable if surgical risk is low. Medical therapy plays a supportive role and focuses on treating hypertension and heart failure symptoms. ACE inhibitors or angiotensin receptor blockers are recommended for blood pressure control, and diuretics with sodium restriction are used for congestive heart failure. Long-term vasodilator therapy has not consistently been shown to delay surgery in asymptomatic patients with severe AR but is appropriate for concomitant hypertension. Beta-blockers may be considered in patients with symptomatic severe AR or left ventricular dysfunction when surgery is not feasible, and observational studies suggest a potential survival benefit in such cases. For patients with pure aortic insufficiency who are not surgical candidates, TAVR may be considered, although it is associated with higher rates of certain complications compared with surgical valve replacement.
Referral for surgical or advanced cardiac evaluation is indicated in patients with acute severe AR, symptomatic severe AR, evidence of left ventricular systolic dysfunction, or significant ventricular dilation even in the absence of symptoms. With timely intervention and appropriate long-term follow-up, outcomes in patients with chronic AR can be significantly improved, particularly when surgery is performed before irreversible left ventricular dysfunction develops.
0 Comments
